Pharma Journalist -

AgeX Therapeutics, Inc. a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a research collaboration with the University of…
Read More...

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, and Foghorn Therapeutics Inc. announced a strategic collaboration to create novel oncology medicines…
Read More...

Pfizer Inc. and Arena Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company…
Read More...

SMi Group reports: CTO and Co-Founder of Envisagenics, Martin Akerman discusses the challenges and developments in the RNA industry SMi’s 13th Annual RNA Therapeutics Conference will…
Read More...

Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZeneca. The partnership is based on an expanded deal this year in May 2021 which…
Read More...

Novo Nordisk announced plans to invest more than 17 bn Danish kroner in construction of three new manufacturing facilities as well as expansion of one existing facility at its…
Read More...

Pfizer Inc. announced that the European Commission (EC) has approved the 100 mg and 200 mg doses of Cibinqo (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for the…
Read More...

Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies…
Read More...

SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.…
Read More...

SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference. SMi Group is delighted to announce the return of the successful 3D Cell Culture…
Read More...